Literature DB >> 7529655

Fetal marrow suppression after maternal chemotherapy for leukaemia.

N A Murray1, D Acolet, M Deane, J Price, I A Roberts.   

Abstract

A preterm baby, whose mother received chemotherapy for acute leukaemia during pregnancy, required intensive care because of profound anaemia and neutropenia. Haemopoietic progenitor cell studies showed fetal marrow suppression. Those caring for such mothers and babies should know the possible serious effects chemotherapy for malignancies can have on a developing fetus. Long term follow up of the baby is imperative.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529655      PMCID: PMC1061127          DOI: 10.1136/fn.71.3.f209

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  5 in total

1.  Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.

Authors:  A Avilés; J C Díaz-Maqueo; A Talavera; R Guzmán; E L García
Journal:  Am J Hematol       Date:  1991-04       Impact factor: 10.047

2.  Transplacental effects of maternal cancer chemotherapy. Case report.

Authors:  A Raffles; J Williams; K Costeloe; P Clark
Journal:  Br J Obstet Gynaecol       Date:  1989-09

3.  Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours.

Authors:  J Pedersen-Bjergaard; G Daugaard; S W Hansen; P Philip; S O Larsen; M Rørth
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

4.  Combination chemotherapy with conservative obstetric management in the treatment of pregnant patients with acute myeloblastic leukaemia.

Authors:  V Roy; C N Gutteridge; A Nysenbaum; A C Newland
Journal:  Clin Lab Haematol       Date:  1989

5.  Erythroid progenitors (BFU-e and CFU-e) in acute leukaemia.

Authors:  A Urabe; M J Murphy; M Haghbin; T S Gee
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

  5 in total
  1 in total

1.  Undetected Severe Fetal Myelosuppression following Administration of High-Dose Cytarabine for Acute Myeloid Leukemia: Is More Frequent Surveillance Necessary?

Authors:  Jessica Parrott; Marium Holland
Journal:  Case Rep Obstet Gynecol       Date:  2017-09-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.